157 related articles for article (PubMed ID: 19535894)
1. Delta-glycated hemoglobin: a novel independent risk factor for cardiovascular events in patients without diabetes mellitus.
Diedrichs H; Pfister R; Clement Z; Hagemeister J; Schneider CA
J Endocrinol Invest; 2009 Jul; 32(7):564-7. PubMed ID: 19535894
[TBL] [Abstract][Full Text] [Related]
2. Association of Longitudinal Values of Glycated Hemoglobin With Cardiovascular Events in Patients With Type 2 Diabetes and Multivessel Coronary Artery Disease.
Rezende PC; Hlatky MA; Hueb W; Garcia RMR; da Silva Selistre L; Lima EG; Garzillo CL; Scudeler TL; Boros GAB; Ribas FF; Serrano CV; Ramires JAF; Kalil Filho R
JAMA Netw Open; 2020 Jan; 3(1):e1919666. PubMed ID: 31968117
[TBL] [Abstract][Full Text] [Related]
3. Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CR; Leite NC; Ferreira MT; Salles GF
Acta Diabetol; 2015 Feb; 52(1):21-9. PubMed ID: 24816865
[TBL] [Abstract][Full Text] [Related]
4. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
[TBL] [Abstract][Full Text] [Related]
5. Greater HbA1c variability is associated with increased cardiovascular events in type 2 diabetes patients with preserved renal function, but not in moderate to advanced chronic kidney disease.
Lee MY; Hsiao PJ; Huang YT; Huang JC; Hsu WH; Chen SC; Shin SJ
PLoS One; 2017; 12(6):e0178319. PubMed ID: 28591149
[TBL] [Abstract][Full Text] [Related]
6. Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.
Eeg-Olofsson K; Zethelius B; Gudbjörnsdottir S; Eliasson B; Svensson AM; Cederholm J
Diab Vasc Dis Res; 2016 Jul; 13(4):268-77. PubMed ID: 27190080
[TBL] [Abstract][Full Text] [Related]
7. Hemoglobin A1c is a better predictor of prognosis following the non-ST elevation acute coronary syndrome than fasting and admission glucose.
Kmet M; Rajer B; Pernat A
Wien Klin Wochenschr; 2014 Mar; 126(5-6):156-62. PubMed ID: 24297265
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study.
Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH
J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206
[TBL] [Abstract][Full Text] [Related]
9. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.
Kassaian SE; Goodarzynejad H; Boroumand MA; Salarifar M; Masoudkabir F; Mohajeri-Tehrani MR; Pourhoseini H; Sadeghian S; Ramezanpour N; Alidoosti M; Hakki E; Saadat S; Nematipour E
Cardiovasc Diabetol; 2012 Jul; 11():82. PubMed ID: 22805289
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin A1C in non-diabetic patients: an independent predictor of coronary artery disease and its severity.
Ashraf H; Boroumand MA; Amirzadegan A; Talesh SA; Davoodi G
Diabetes Res Clin Pract; 2013 Dec; 102(3):225-32. PubMed ID: 24176244
[TBL] [Abstract][Full Text] [Related]
11. Glycemic Control Status After Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients With Type 2 Diabetes Mellitus.
Hwang JK; Lee SH; Song YB; Ahn J; Carriere K; Jang MJ; Park TK; Choi SH; Yang JH; Choi JH; Lee SH; Gwon HC; Hahn JY
Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28373177
[TBL] [Abstract][Full Text] [Related]
12. Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus.
Rhee JJ; Zheng Y; Montez-Rath ME; Chang TI; Winkelmayer WC
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28592463
[TBL] [Abstract][Full Text] [Related]
13. Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.
Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728374
[TBL] [Abstract][Full Text] [Related]
14. Hemoglobin A
She J; Deng Y; Wu Y; Xia Y; Li H; Liang X; Shi R; Yuan Z
Cardiovasc Diabetol; 2017 Aug; 16(1):97. PubMed ID: 28789650
[TBL] [Abstract][Full Text] [Related]
15. Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
Penno G; Solini A; Zoppini G; Orsi E; Fondelli C; Zerbini G; Morano S; Cavalot F; Lamacchia O; Trevisan R; Vedovato M; Pugliese G;
Cardiovasc Diabetol; 2013 Jul; 12():98. PubMed ID: 23829205
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.
Cavender MA; Scirica BM; Raz I; Steg PG; McGuire DK; Leiter LA; Hirshberg B; Davidson J; Cahn A; Mosenzon O; Im K; Braunwald E; Bhatt DL
Am J Med; 2016 Mar; 129(3):340.e1-8. PubMed ID: 26524706
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
[TBL] [Abstract][Full Text] [Related]
18. Role of relationship between HbA1c, fibrinogen and HDL-cholesterol on cardiovascular disease in patients with type 2 diabetes mellitus.
Pacilli A; De Cosmo S; Trischitta V; Bacci S
Atherosclerosis; 2013 May; 228(1):247-8. PubMed ID: 23466074
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
Liu SL; Wu NQ; Shi HW; Dong Q; Dong QT; Gao Y; Guo YL; Li JJ
Cardiovasc Diabetol; 2020 Mar; 19(1):36. PubMed ID: 32192491
[TBL] [Abstract][Full Text] [Related]
20. The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial.
van Steen SC; Schrieks IC; Hoekstra JB; Lincoff AM; Tardif JC; Mellbin LG; Rydén L; Grobbee DE; DeVries JH;
Eur J Prev Cardiol; 2017 May; 24(8):858-866. PubMed ID: 28186441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
